Extracellular proteomes of M-CSF (CSF-1) and GM-CSF-dependent macrophages

Immunology and Cell Biology

Volumn 89, Issue 2, 2011, Pages 283-293

  Bailey, Mark J ^a,c,d   Lacey, Derek C ^a   De Kok, Bernard V A ^a   Veith, Paul D ^b   Reynolds, Eric C ^b   Hamilton, John A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

granulocyte macrophage colony stimulating factor (GM CSF); macrophage colony stimulating factor (M CSF); macrophages; proteomics; secretion

Indexed keywords

CATHEPSIN; COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROTEIN C19ORF10; PROTEIN DERIVATIVE; PROTEOME; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; IMMUNE RESPONSE; MACROPHAGE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; SYNOVIAL FLUID; TISSUE REGENERATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BLOTTING, WESTERN; COMPUTATIONAL BIOLOGY; CULTURE MEDIA, CONDITIONED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXTRACELLULAR SPACE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKINS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, INBRED C57BL; PROTEIN TRANSPORT; PROTEOME;

MURINAE;

EID: 79951957545     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.92     Document Type: Article

References (91)

1. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35. (Pubitemid 37328697)
2. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209-212. (Pubitemid 36158295)
3. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005; 23: 344-346. (Pubitemid 41443435)
4. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 2005; 23: 901-944. (Pubitemid 40563189)
5. al-Sarireh B, Eremin O. Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb 2000; 45: 1-16.
6. Bailey C, Negus R, Morris A, Ziprin P, Goldin R, Allavena P et al. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin Exp Metastasis 2007; 24: 121-130. (Pubitemid 46669245)
7. Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 1980; 56: 947-958. (Pubitemid 11205044)
8. Hamilton JA, Stanley ER, Burgess AW, Shadduck RK. Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol 1980; 103: 435-445. (Pubitemid 11104577)
9. Akagawa KS. Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages. Int J Hematol 2002; 76: 27-34. (Pubitemid 43020277)
10. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8: 533-544. (Pubitemid 351913679)
11. Falk LA, Vogel SN. Comparison of bone marrow progenitors responsive to granulocyte-macrophage colony stimulating factor and macrophage colony stimulating factor-1. J Leukoc Biol 1988; 43: 148-157. (Pubitemid 18062543)
12. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005; 307: 1630-1634. (Pubitemid 40354746)
13. Lari R, Fleetwood AJ, Kitchener PD, Cook AD, Pavasovic D, Hertzog PJ et al. Macrophage lineage phenotypes and osteoclastogenesis-complexity in the control by GM-CSF and TGF-beta. Bone 2007; 40: 323-336. (Pubitemid 46054560)
14. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 2007; 178: 5245-5252. (Pubitemid 46595309)
15. Vairo G, Hamilton JA. CSF-1 stimulates Na+K+-ATPase mediated 86Rb+ uptake in mouse bone marrow-derived macrophages. Biochem Biophys Res Commun 1985; 132: 430-437. (Pubitemid 16196163)
16. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J ExpMed 1992; 176: 1693-1702.
17. Jackson SH, Alicea C, Owens JW, Eigsti CL, Malech HL. Characterization of an early dendritic cell precursor derived from murine lineage-negative hematopoietic progenitor cells. Exp Hematol 2002; 30: 430-439. (Pubitemid 34556734)
18. Tadokoro CE, de Almeida Abrahamsohn I. Bone marrow-derived macrophages grown in GM-CSF or M-CSF differ in their ability to produce IL-12 and to induce IFN-gamma production after stimulation with Trypanosoma cruzi antigens. Immunol Lett 2001; 77: 31-38. (Pubitemid 32434413)
19. Fleetwood AJ, Dinh H, Cook AD, Hertzog PJ, Hamilton JA. GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leukoc Biol 2009; 86: 411-421.
20. Fischer HG, Frosch S, Reske K, Reske-Kunz AB. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J Immunol 1988; 141: 3882-3888.
21. Phillips WA, Hamilton JA. Colony stimulating factor-1 is a negative regulator of the macrophage respiratory burst. J Cell Physiol 1990; 144: 190-196.
22. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101: 4560-4565. (Pubitemid 38437450)
23. Dupont A, Tokarski C, Dekeyzer O, Guihot AL, Amouyel P, Rolando C et al. Two-dimensional maps and databases of the human macrophage proteome and secretome. Proteomics 2004; 4: 1761-1778. (Pubitemid 38738331)
24. Dinnes DL, Marcal H, Mahler SM, Santerre JP, Labow RS. Material surfaces affect the protein expression patterns of human macrophages: a proteomics approach. J Biomed Mater Res A 2007; 80: 895-908.
25. Kobayashi R, Deavers M, Patenia R, Rice-Stitt T, Halbe J, Gallardo S et al. 14-3-3 Zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients. Cancer Immunol Immunother 2009; 58: 247-258.
26. Garcia K, Garcia V, Perez Laspiur J, Duan F, Melendez LM. Characterization of the placental macrophage secretome: implications for antiviral activity. Placenta 2009; 30: 149-155.
27. Nair R, Rost B. Mimicking cellular sorting improves prediction of subcellular localization. J Mol Biol 2005; 348: 85-100. (Pubitemid 40461842)
28. Klee EW, Sosa CP. Computational classification of classically secreted proteins. Drug Discov Today 2007; 12: 234-240.
29. Zwickl H, Traxler E, Staettner S, Parzefall W, Grasl-Kraupp B, Karner J et al. A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis 2005; 26: 2779-2785. (Pubitemid 41078987)
30. Dupont A, Corseaux D, Dekeyzer O, Drobecq H, Guihot AL, Susen S et al. The proteome and secretome of human arterial smooth muscle cells. Proteomics 2005; 5: 585-596. (Pubitemid 40262075)
31. Kubota K, Wakabayashi K, Matsuoka T. Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: two-dimensional electrophoresis and isotope-coded affinity tags analysis with two-dimensional chromatography. Proteomics 2003; 3: 616-626. (Pubitemid 36570253)
32. Chevallet M, Diemer H, Van Dorssealer A, Villiers C, Rabilloud T. Toward a better analysis of secreted proteins: the example of the myeloid cells secretome. Proteomics 2007; 7: 1757-1770. (Pubitemid 46910996)
33. Wang P, Mariman E, Keijer J, Bouwman F, Noben JP, Robben J et al. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell Mol Life Sci 2004; 61: 2405-2417. (Pubitemid 39382030)
34. Gronborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, Sato N et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006; 5: 157-171. (Pubitemid 43169348)
35. Thouvenot E, Lafon-Cazal M, Demettre E, Jouin P, Bockaert J, Marin P. The proteomic analysis of mouse choroid plexus secretome reveals a high protein secretion capacity of choroidal epithelial cells. Proteomics 2006; 6: 5941-5952. (Pubitemid 44851380)
36. Pellitteri-Hahn MC, Warren MC, Didier DN, Winkler EL, Mirza SP, Greene AS et al. Improved mass spectrometric proteomic profiling of the secretome of rat vascular endothelial cells. J Proteome Res 2006; 5: 2861-2864. (Pubitemid 44595186)
37. Smalheiser NR. Proteins in unexpected locations. Mol Biol Cell 1996; 7: 1003-1014. (Pubitemid 26244199)
38. Inaba K, Steinman RM, Pack MW, Aya H, Inaba M, Sudo T et al. Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 1992; 175: 1157-1167.
39. Fach EM, Garulacan LA, Gao J, Xiao Q, Storm SM, Dubaquie YP et al. In vitro biomarker discovery for atherosclerosis by proteomics. Mol Cell Proteomics 2004; 3: 1200-1210.
40. Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B. Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des 2007; 13: 387-403. (Pubitemid 46477760)
41. Reilly Jr JJ, Chen P, Sailor LZ, Mason RW, Chapman Jr HA. Uptake of extracellular enzyme by a novel pathway is a major determinant of cathepsin L levels in human macrophages. J Clin Invest 1990; 86: 176-183. (Pubitemid 20226990)
42. Weiler T, Du Q, Krokhin O, Ens W, Standing K, El-Gabalawy H et al. The identification and characterization of a novel protein, c19orf10, in the synovium. Arthritis Res Ther 2007; 9: R30.
43. Dasuri K, Antonovici M, Chen K, Wong K, Standing K, Ens W et al. The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res Ther 2004; 6: R161-R168.
44. Ji H, Moritz RL, Kim YS, Zhu HJ, Simpson RJ. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics. Electrophoresis 2007; 28: 1997-2008. (Pubitemid 47040405)
45. Tulin EE, Onoda N, Nakata Y, Maeda M, Hasegawa M, Nomura H et al. SF20/IL-25, a novel bone marrow stroma-derived growth factor that binds to mouse thymic shared antigen-1 and supports lymphoid cell proliferation. J Immunol 2001; 167: 6338-6347. (Pubitemid 33081565)
46. Tulin EE, Onoda N, Nakata Y, Maeda M, Hasegawa M, Nomura H et al. SF20/IL-25, a novel bone marrow stroma-derived growth factor that binds to mouse thymic shared antigen-1 and supports lymphoid cell proliferation. J Immunol 2003; 170: 1593. (Pubitemid 36139532)
47. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol 2006; 79: 285-293. (Pubitemid 44831160)
48. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008; 13: 453-461. (Pubitemid 351599757)
49. Way KJ, Dinh H, Keene MR, White KE, Clanchy FI, Lusby P et al. The generation and properties of human macrophage populations from hemopoietic stem cells. J Leukoc Biol 2009; 85: 766-778.
50. Nishino J, Yamashita K, Hashiguchi H, Fujii H, Shimazaki T, Hamada H. Meteorin: a secreted protein that regulates glial cell differentiation and promotes axonal extension. EMBO J 2004; 23: 1998-2008. (Pubitemid 38902078)
51. Park JA, Lee HS, Ko KJ, Park SY, Kim JH, Choe G et al. Meteorin regulates angiogenesis at the gliovascular interface. Glia 2008; 56: 247-258.
52. He Z, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med 2003; 81: 600-612. (Pubitemid 37357675)
53. He Z, Ong CH, Halper J, Bateman A. Progranulin is a mediator of the wound response. Nat Med 2003; 9: 225-229. (Pubitemid 36227726)
54. Shibutani T, Yamashita K, Aoki T, Iwayama Y, Nishikawa T, Hayakawa T. Tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) stimulate osteoclastic bone resorption. J Bone Miner Metab 1999; 17: 245-251.
55. Cook H, Davies KJ, Harding KG, Thomas DW. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol 2000; 115: 225-233. (Pubitemid 30637192)
56. Dew G, Murphy G, Stanton H, Vallon R, Angel P, Reynolds JJ et al. Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone. Cell Tissue Res 2000; 299: 385-394. (Pubitemid 30160447)
57. Paul AG, van Kooten PJ, van Eden W, van der Zee R. Highly autoproliferative T cells specific for 60-kDa heat shock protein produce IL-4/IL-10 and IFN-gamma and are protective in adjuvant arthritis. J Immunol 2000; 165: 7270-7277. (Pubitemid 32001206)
58. Quintana FJ, Carmi P, Mor F, Cohen IR. Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J Immunol 2002; 169: 3422-3428. (Pubitemid 35013193)
59. Prakken BJ, Roord S, van Kooten PJ, Wagenaar JP, van Eden W, Albani S et al. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heatshock protein 60T cell epitope. Arthritis Rheum 2002; 46: 1937-1946. (Pubitemid 34774527)
60. Misasi R, Garofalo T, Di Marzio L, Mattei V, Gizzi C, Hiraiwa M et al. Prosaposin: a new player in cell death prevention of U937 monocytic cells. Exp Cell Res 2004; 298: 38-47. (Pubitemid 38887305)
61. Petersson U, Somogyi E, Reinholt FP, Karlsson T, Sugars RV, Wendel M. Nucleobindin is produced by bone cells and secreted into the osteoid, with a potential role as a modulator of matrix maturation. Bone 2004; 34: 949-960. (Pubitemid 38749232)
62. Zhou HY. Proteomic analysis of hydroxyapatite interaction proteins in bone. Ann NY Acad Sci 2007; 1116: 323-326.
63. Chang NC, Hung SI, Hwa KY, Kato I, Chen JE, Liu CH et al. A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J Biol Chem 2001; 276: 17497-17506.
64. Wang X, Liang J, Koike T, Sun H, Ichikawa T, Kitajima S et al. Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits. Am J Pathol 2004; 165: 1375-1383. (Pubitemid 39297741)
65. Liu M, Sun H, Wang X, Koike T, Mishima H, Ikeda K et al. Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis. Arthritis Rheum 2004; 50: 3112-3117. (Pubitemid 39371986)
66. Krutilina RI, Kropotov AV, Leutenegger C, Serikov VB. Migrating leukocytes are the source of peroxiredoxin V during inflammation in the airways. J Inflamm (Lond) 2006; 3: 13.
67. Avila PC, Kropotov AV, Krutilina R, Krasnodembskay A, Tomilin NV, Serikov VB. Peroxiredoxin V contributes to antioxidant defense of lung epithelial cells. Lung 2008; 186: 103-114.
68. Hernandez-Ruiz L, Valverde F, Jimenez-Nunez MD, Ocana E, Saez-Benito A, Rodriguez- Martorell J et al. Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res 2007; 6: 4449-4457. (Pubitemid 350158520)
69. Kitanaka N, Owada Y, Okuyama R, Sakagami H, Nourani MR, Aiba S et al. Epidermal-type fatty acid binding protein as a negative regulator of IL-12 production in dendritic cells. Biochem Biophys Res Commun 2006; 345: 459-466.
70. Erlandsson Harris H, Andersson U. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 2004; 34: 1503-1512. (Pubitemid 39256031)
71. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol 2007; 81: 49-58. (Pubitemid 46021252)
72. Sha Y, Zmijewski J, Xu Z, Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 2008; 180: 2531-2537.
73. Fritsch R, Eselbock D, Skriner K, Jahn-Schmid B, Scheinecker C, Bohle B et al. Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis. J Immunol 2002; 169: 1068-1076. (Pubitemid 34753467)
74. Greidinger EL, Gazitt T, Jaimes KF, Hoffman RW. Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production. Arthritis Rheum 2004; 50: 2216-2222. (Pubitemid 38924400)
75. Fritsch-Stork R, Mullegger D, Skriner K, Jahn-Schmid B, Smolen JS, Steiner G. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus. Arthritis Res Ther 2006; 8: R118.
76. Schett G, Dumortier H, Hoefler E, Muller S, Steiner G. B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease. Ann Rheum Dis 2009; 68: 729-735.
77. Zaheer A, Knight S, Ahrens M, Sahu SK, Yang B. Glia maturation factor overexpression in neuroblastoma cells activates glycogen synthase kinase-3beta and caspase-3. Brain Res 2008; 1190: 206-214.
78. Shi Y, Chen L, Liotta LA, Wan HH, Rodgers GP. Glia maturation factor gamma (GMFG): a cytokine-responsive protein during hematopoietic lineage development and its functional genomics analysis. Genomics Proteomics Bioinformatics 2006; 4: 145-155. (Pubitemid 44792017)
79. Eustace BK, Jay DG. Extracellular roles for the molecular chaperone, hsp90. Cell Cycle 2004; 3: 1098-1100. (Pubitemid 40268620)
80. Eustace BK, Sakurai T, Stewart JK, Yimlamai D, Unger C, Zehetmeier C et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 2004; 6: 507-514. (Pubitemid 38786593)
81. Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E. A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. J Biol Chem 2008; 283: 2031-2041.
82. Sidera K, Patsavoudi E. Extracellular HSP90: conquering the cell surface. Cell Cycle 2008; 7: 1564-1568. (Pubitemid 351881322)
83. Kerkhoff C, Klempt M, Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1998; 1448: 200-211. (Pubitemid 29052193)
84. Ryckman C, McColl SR, Vandal K, de Medicis R, Lussier A, Poubelle PE et al. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 2003; 48: 2310-2320. (Pubitemid 36959213)
85. Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004; 344: 37-51. (Pubitemid 38626135)
86. Foell D, Wittkowski H, Ren Z, Turton J, Pang G, Daebritz J et al. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol 2008; 216: 183-192.
87. Mbeunkui F, Fodstad O, Pannell LK. Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J Proteome Res 2006; 5: 899-906.
88. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004; 340: 783-795. (Pubitemid 38829638)
89. Bendtsen JD, Jensen LJ, Blom N, Von Heijne G, Brunak S. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 2004; 17: 349-356. (Pubitemid 39093515)
90. Duckert P, Brunak S, Blom N. Prediction of proprotein convertase cleavage sites. Protein Eng Des Sel 2004; 17: 107-112. (Pubitemid 38173174)
91. Hofmann K, Stoffell W. A database of membrane spanning protein segments. Biol Chem Hoppe-Seyler 1993; 374: 166.